Tag: Hepatitis C | Page 9

Déjà vu: Canada’s drug reviewers again mired in bureaucracy

February 16, 2015 • By Adam Cook

The development of treatment for the cure of hepatitis C (HCV) is moving at a dizzying pace. Indeed, the entire HCV story is one of an unusually fast trajectory, not only the speed of treatment development, but also the spread of the virus. While early cures were injection-based, difficult to tolerate, and boasting a mere 50% success rate after a year of treatment, there now exist cures that involve one pill, once a day, for a regimen that often doesn’t exceed twelve weeks. There are clinical trials being conducted presently to evaluate the efficacy of new treatments at eight and...

Program science: Taking the guesswork out of prevention

February 2, 2015 • By Zak Knowles

For those of us who work in HIV and Hep C prevention, the advent of new prevention approaches has made us increasingly dependent on evidence for making informed decisions about the best strategies to use with a particular client or community.

Share and conquer: Pooling our programming know-how

January 12, 2015 • By Erica Lee

A while back, CATIE wanted to find out what’s been done across the country to assess the frontline needs of HIV and hepatitis C service providers and service users. As the information specialist (or librarian) here at CATIE, I was duly tasked with locating whatever reports I could find.

Where do we go from here?

November 19, 2014 • By Laurie Edmiston

Recently I was asked to speak at an event organized by Alex McClelland and Nicole Greenspan called “Where Do We Go From Here? AIDS Organizing, Services, Bureaucracy & the State.” The event aimed to address a number of questions, including: What are the limits of current community-based practice based on engagement with the state? Are today’s AIDS service organizations (ASOs) adequately resourced and designed to undertake their intended role? Is the role sufficient to address the ongoing and emerging HIV issues that marginalized communities face? Due to state constraints, what are the consequences on advocacy possibilities for ASOs, or ASO...